Cerevel Therapeutics Holdings, Inc.
CEREDelisted Aug 1, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001805387
Cerevel Therapeutics Holdings, Inc. was delisted on Aug 1, 2024; its insiders filed their last Form 4 on Aug 5, 2024; 231 institutions reported holding it in 13F filings for Q2 2024, worth $6.42B in total; Soros Fund Management was the only superinvestor holding it.
Holders of 5% or more of CERE
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Cerevel Therapeutics Holdings, Inc., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Cerevel Therapeutics Holdings, Inc. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
22 Schedule 13D and 13G filings on Cerevel Therapeutics Holdings, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Aug 5, 2024 | BC Perception Holdings, LP | 13D/AOld format | – | – | – | SEC |
| Aug 5, 2024 | Pfizer Inc | 13D/AOld format | – | – | – | SEC |
| May 10, 2024 | FMR LLC | 13G/AOld format | – | – | – | SEC |
| Jan 10, 2024 | FMR LLC | 13G/AOld format | – | – | – | SEC |
| Dec 8, 2023 | BC Perception Holdings, LP | 13D/AOld format | – | – | – | SEC |
| Oct 18, 2023 | BC Perception Holdings, LP | 13D/AOld format | – | – | – | SEC |
| Oct 18, 2023 | Pfizer Inc | 13D/AOld format | – | – | – | SEC |
| Oct 17, 2023 | Perceptive Advisors LLC | 13D/AOld format | – | – | – | SEC |
| Apr 25, 2023 | Perceptive Advisors LLC | 13D/AOld format | – | – | – | SEC |
| Apr 21, 2023 | Perceptive Advisors LLC | 13DOld format | – | New | – | SEC |
| Feb 9, 2023 | FMR LLC | 13G/AOld format | – | – | – | SEC |
| Aug 18, 2022 | BC Perception Holdings, LP | 13D/AOld format | – | – | – | SEC |
| Apr 7, 2022 | Pfizer Inc | 13D/AOld format | – | – | – | SEC |
| Mar 3, 2022 | BC Perception Holdings, LP | 13D/AOld format | – | – | – | SEC |
| Feb 9, 2022 | FMR LLC | 13G/AOld format | – | – | – | SEC |
| Sep 17, 2021 | Pfizer Inc | 13D/AOld format | – | – | – | SEC |
| Aug 10, 2021 | FMR LLC | 13GOld format | – | New | – | SEC |
| Jul 9, 2021 | BC Perception Holdings, LP | 13D/AOld format | – | – | – | SEC |
| Jul 9, 2021 | Pfizer Inc | 13D/AOld format | – | – | – | SEC |
| Jun 10, 20211:01 PM ET | Federated Hermes, Inc. | 13G/AOld format | – | – | – | SEC |
| Apr 9, 20212:17 PM ET | Federated Hermes, Inc. | 13G/AOld format | – | – | – | SEC |
| Feb 12, 20213:06 PM ET | Federated Hermes, Inc. | 13GOld format | – | New | – | SEC |
Form 144: proposed insider sales
27 notices from officers, directors and other affiliates planning to sell Cerevel Therapeutics Holdings, Inc. shares, newest first.
| Filed (ET) | Seller | Shares to sell | Market value | Planned sale | Broker | Filing |
|---|---|---|---|---|---|---|
| Jul 1, 20244:46 PM ET | Neavelle Anthony ColesDirector · Officer | 25.0K | $1.02M | Jul 1, 202410b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Jun 3, 20244:58 PM ET | Neavelle Anthony ColesDirector · Officer | 50.0K | $2.04M | Jun 3, 202410b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| May 10, 20244:27 PM ET | Neavelle Anthony ColesDirector | 50.0K | $2.12M | May 10, 202410b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Apr 1, 20244:31 PM ET | Neavelle Anthony ColesDirector · Officer | 50.0K | $2.11M | Apr 1, 202410b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Mar 4, 20245:36 PM ET | Neavelle Anthony ColesDirector · Officer | 50.0K | $2.05M | Mar 4, 202410b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Feb 29, 20244:19 PM ET | Neavelle Anthony ColesDirector · Officer | 50.0K | $2.06M | Feb 29, 202410b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Jan 2, 20244:33 PM ET | Neavelle Anthony ColesDirector · Officer | 50.0K | $2.12M | Jan 2, 202410b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Dec 26, 20235:03 PM ET | Ramiro SanchezOfficer | 10.0K | $424.7K | Dec 26, 202310b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Dec 22, 20233:56 PM ET | DiPietro KennethOfficer | 8.00K | $331.6K | Dec 22, 2023 | Morgan Stanley Smith Barney LLC Executive Services | SEC |
| Dec 15, 20236:34 PM ET | Sanchez RamiroOfficer | 7.50K | $310.4K | Dec 15, 2023 | Morgan Stanley Smith Barney LLC Executive Services | SEC |
| Dec 7, 20234:32 PM ET | Scott AkamineOfficer | 10.0K | $413.7K | Dec 7, 202310b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Dec 7, 20234:31 PM ET | Ramiro SanchezOfficer | 10.0K | $413.7K | Dec 7, 202310b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Dec 5, 20236:42 PM ET | Scott AkamineOfficer | 7.50K | $262.5K | Dec 5, 202310b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Nov 7, 20234:13 PM ET | Neavelle Anthony ColesDirector · Officer | 50.0K | $1.25M | Nov 7, 202310b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Nov 3, 20234:25 PM ET | Neavelle Anthony ColesDirector · Officer | 50.0K | $1.24M | Nov 3, 202310b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Nov 2, 20234:05 PM ET | Neavelle Anthony ColesDirector · Officer | 50.0K | $1.27M | Nov 2, 202310b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Nov 1, 20234:39 PM ET | Deval PatrickDirector | 30.1K | $753.3K | Nov 1, 202310b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Sep 7, 20234:17 PM ET | Neavelle Anthony ColesDirector · Officer | 50.0K | $1.21M | Sep 7, 202310b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Jul 11, 20234:27 PM ET | Neavelle Anthony ColesDirector · Officer | 50.0K | $1.53M | Jul 11, 202310b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Jun 15, 20234:36 PM ET | Novalis LifeSciences Investments I, L.P.Stockholder (1) see Remarks | 200.0K | $6.89M | Jun 15, 2023 | Cowan and Company, LLC | SEC |
| Jun 5, 20238:52 PM ET | Bodenrader MarkOfficer | 1.90K | $62.4K | Jun 2, 2023 | ETRADE FINANCIAL CORPORATION | SEC |
| Jun 1, 20234:19 PM ET | Neavelle Anthony ColesDirector · Officer | 50.0K | $1.63M | Jun 1, 202310b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| May 8, 20237:03 PM ETAmended | Ceesay AbrahamOfficer | 35.2K | $1.13M | May 8, 2023 | ETRADE FINANCIAL CORPORATION | SEC |
| May 5, 20233:15 PM ET | Ceesay AbrahamOfficer | 35.2K | $1.11M | May 5, 2023 | ETRADE FINANCIAL CORPORATION | SEC |
| May 4, 20234:31 PM ET | Neavelle Anthony ColesDirector · Officer | 50.0K | $1.60M | May 4, 202310b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
Showing the latest 25. See the CERE notices from the last 12 months